Health and Healthcare

Health and Healthcare Articles

A new large-scale study conducted by Korean researchers, the results of which were just published in the European Heart Journal, has established a significant link between the common cardiac...
Ocular Therapeutix shares jumped on Friday after the firm announced that the U.S. Food and Drug Administration (FDA) approved a Supplemental New Drug Application (sNDA) for Dextenza to include the...
Marijuana trends showing higher use after cannabis legalization in Canada.
Swiss researchers have established that tannins found in pomegranates are converted in the digestive system into a compound that appears to slow down mitochondrial aging — a natural process that...
Melinta Therapeutics shares nearly doubled early on Wednesday after the firm announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for...
Health care stocks still have plenty of upside in them. Agilent, Danaher, Thermo Fisher are all stocks to buy.
Analyst Yun Zhong looks at two treatments for Alzheimer Disease and other dementias that could beat the odds and be winners in treating these awful afflictions.
24/7 Wall St. has picked a few of those standouts from Tuesday to highlight. We have included information about each company, as well as recent trading activity and the consensus price target.
PhaseBio Pharmaceuticals shares jumped on Tuesday after the firm announced preliminary results from its mid-stage trial on subjects on dual antiplatelet therapy of ticagrelor and low-dose aspirin.
Baldness is something that many men fear as they age, and understandably so. But Aclaris Therapeutics may have found an answer to it in its most recent mid-stage clinical trial.
A blood pressure medication widely used in Europe and Japan might have potential to slow down the progress of Alzheimer’s disease, according to a new study appearing in Hypertension, a journal...
Array BioPharma shares shot up on Monday after the firm announced that it would be acquired by Pfizer in an all cash transaction. The boards of directors of both companies have approved the merger...
Annual deaths from cancer have dropped 27% in the last 25 years, according to the American Cancer Society (ACS). However, the death rates for some have barely dropped, and some forms will still kill...
Heat waves swung through Phoenix the week and pushed temperatures as high as 110 degrees Fahrenheit. In New Delhi, India, the temperature rose close to 120 but was pushed down fairly quickly by...
Merck is set to host its Investor Day on June 20. Investors will have a high bar of expectations because so much of Merck's story is known.
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.